Many patients undergo lung cancer screening despite having a higher likelihood of experiencing harm rather than benefit.
Recent data suggest that the World Health Organization's recommendation on this question should be individualized.
In clinical trials of cancer screening, the incidence of late-stage cancer works as well as cancer-specific mortality as an ...
There is no increased relapse risk in patients with multiple sclerosis and comorbid cancer who are taking checkpoint ...
Lidocaine injections into the greater occipital nerve relieve severe, refractory migraine attacks in children, results of a ...
Young breast cancer survivors with a germline pathogenic variant or who are initially diagnosed with in situ disease have ...
Only a minority of genome-targeted cancer drugs recently approved in the United States demonstrate significant clinical ...
A small study suggests that conversations between hospice and referring providers can help ease transitions to end-of-life ...
Although the overall incidence remains low, patients on GLP-1s have a 33% higher chance of aspiration pneumonia after ...
Last year saw more than 50 new drug approvals, many of which may help internists better manage several common conditions in ...
Growth hormone deficiency appears to be linked to a particular microbiome signature that could help with the early diagnosis ...
A pilot study suggests the ketogenic diet may ease symptoms of schizophrenia and bipolar disorder and reduce weight gain ...